361 related articles for article (PubMed ID: 8271029)
1. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
[TBL] [Abstract][Full Text] [Related]
2. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
3. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
4. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography].
Sakamoto S
Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):222-34. PubMed ID: 2376611
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
6. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.
Ishii K; Kitagaki H; Kono M; Mori E
J Nucl Med; 1996 Jul; 37(7):1159-65. PubMed ID: 8965188
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
8. [Measurements of cerebral blood flow and metabolism in patients with Alzheimer's disease].
Kitamura S; Terashi A
Rinsho Byori; 1990 May; 38(5):494-8. PubMed ID: 2381074
[TBL] [Abstract][Full Text] [Related]
9. [Altered energy metabolism in Alzheimer's disease].
Ogawa M; Fukuyama H; Ouchi Y; Yamauchi H; Kimura J
Rinsho Shinkeigaku; 1994 Jan; 34(1):27-31. PubMed ID: 8156707
[TBL] [Abstract][Full Text] [Related]
10. [Cerebral blood flow and cerebral oxygen metabolism in patients with dementia of frontal lobe type].
Kitamura S; Araki T; Sakamoto S; Iio M; Terashi A
Rinsho Shinkeigaku; 1990 Nov; 30(11):1171-5. PubMed ID: 2085920
[TBL] [Abstract][Full Text] [Related]
11. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
[TBL] [Abstract][Full Text] [Related]
12. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients.
Blin J; Ivanoiu A; Coppens A; De Volder A; Labar D; Michel C; Laterre EC
Neuroimage; 1997 Nov; 6(4):335-43. PubMed ID: 9417975
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between the cerebral blood flow, oxygen consumption and glucose metabolism in primary degenerative dementia].
Kuwabara Y; Ichiya Y; Ichimiya A; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1995 Mar; 32(3):253-62. PubMed ID: 7739155
[TBL] [Abstract][Full Text] [Related]
16. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
[TBL] [Abstract][Full Text] [Related]
17. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's dementia.
Chase TN; Tamminga CA
Am J Psychiatry; 1995 Aug; 152(8):1110. PubMed ID: 7625456
[No Abstract] [Full Text] [Related]
19. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
[TBL] [Abstract][Full Text] [Related]
20. Altered energy metabolism in Alzheimer's disease.
Ogawa M; Fukuyama H; Ouchi Y; Yamauchi H; Kimura J
J Neurol Sci; 1996 Jul; 139(1):78-82. PubMed ID: 8836976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
